CMA May Accept Welltower's UK Care Home Remedies, De-risking Acquisition
WELL sits 48% above its 52-week low of $146.645.
Summary
The UK's Competition and Markets Authority (CMA) has indicated it may accept Welltower's proposed remedies for its care home acquisition, suggesting a path to resolve competition concerns. This follows the CMA's formal investigation announced in March and their finding of competition concerns in 30 local areas yesterday. This development is a significant de-risking event for the acquisition, removing regulatory uncertainty. The CMA will now consult on the remedy package and potential buyers.
At the time of this announcement, WELL was trading at $216.60 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $152.5B. The 52-week trading range was $146.65 to $221.68. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.